Recombinant factor VIII Fc (rFVIIIFc) fusion protein reduces immunogenicity and induces tolerance in hemophilia A mice-Reference-Cited by-同舟云学术

Recombinant factor VIII Fc (rFVIIIFc) fusion protein reduces immunogenicity and induces tolerance in hemophilia A mice

Published:2016-03 Issue: Volume:301 Page:30-39
ISSN:0008-8749
Container-title:Cellular Immunology
language:en
Short-container-title:Cellular Immunology

Author:

Krishnamoorthy Sriram,Liu Tongyao,Drager Douglas,Patarroyo-White Susannah,Chhabra Ekta Seth,Peters Robert,Josephson Neil,Lillicrap David,Blumberg Richard S.,Pierce Glenn F.,Jiang Haiyan

Publisher

Elsevier BV

Subject

Immunology

Reference40 articles.

1. C.A. Lee, E.E. Berntorp, W.K. Hoots, Textbook of Hemophilia, 2010.

2. Haemophilia A: from mutation analysis to new therapies;Graw;Nat. Rev. Genet.,2005

3. Recombinant biologics for treatment of bleeding disorders;Bishop;Nat. Rev. Drug Discov.,2004

4. Inhibitory antibodies in hemophilia A;Pratt;Curr. Opin. Hematol.,2012

5. Non-genetic risk factors and their influence on the management of patients in the clinic;Alvarez;Eur. J. Haematol.,2015

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibitor development according to concentrate after 50 exposure days in severe hemophilia: data from the European HAemophilia Safety Surveillance (EUHASS);Research and Practice in Thrombosis and Haemostasis;2024-05

2. The use of Bacillus subtilis as a cost-effective expression system for production of Cholera Toxin B fused factor VIII epitope regions applicable for inducing oral immune tolerance;Folia Microbiologica;2024-04-29

3. Factor IX administration in the skin primes inhibitor formation and sensitizes hemophilia B mice to systemic factor IX administration;Research and Practice in Thrombosis and Haemostasis;2023-11

4. Antigen-dependent modulation of immune responses to antigen-Fc fusion proteins by Fc-effector functions;Frontiers in Immunology;2023-10-05

5. Immunogenicity of Therapeutic Biological Modalities - Lessons from Hemophilia A Therapies;Journal of Pharmaceutical Sciences;2023-09